Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world study

MS Treatments

Jahr

Publikationsjahr
2025

Autoren

Autorenliste der Publikation
Ziemssen T, Bass AD, Van Wijmeersch B, Eichau S, Richter S, Hoffmann F, Armstrong NM, Chirieac M, Cunha-Santos J, Singer BA.

Verlag

Publisher-Information
Ther Adv Neurol Disord. 2025 Feb 10;18:17562864241306575.

Link

Zur Publikation (externer Server)
https://doi.org/10.1177/17562864241306575

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
MSZTreatments2025